Related Experiment Video
Updated: Jun 4, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry.
Xue Hua1, Boris Gutman1, Christina P Boyle1
1Laboratory of Neuro Imaging, Dept. of Neurology, UCLA School of Medicine, Los Angeles, CA, USA.
Neuroimage
|February 16, 2011
Summary
This study refines tensor-based morphometry (TBM) for brain atrophy estimation in serial MRI scans. Enforcing inverse-consistency significantly reduces measurement offsets, improving accuracy for clinical trial power calculations in neurodegenerative diseases.
Area of Science:
- Neuroimaging
- Biomedical Engineering
- Medical Statistics
Background:
- Tensor-based morphometry (TBM) is used to estimate brain changes from serial MRI.
- Previous TBM methods exhibited an unexplained offset in atrophy rates between initial scans.
- This offset could bias power calculations for clinical trials.
Purpose of the Study:
- To address the unexplained offset in TBM-derived atrophy rates.
- To improve the accuracy of TBM for longitudinal neuroimaging analysis.
- To refine sample size estimations for drug trials targeting neurodegenerative diseases.
Main Methods:
- Implemented inverse-consistency enforcement within the TBM framework.
- Analyzed serial MRI data from 431 subjects scanned over 2 years.
- Quantified remaining offsets and attributed them to transitivity errors.
Main Results:
- Enforcing inverse-consistency reduced the initial offset from 1.4% to 0.28%.
- Revised TBM metrics yielded plausible anatomical trajectories.
- Drug trial sample size estimates using the improved TBM were competitive and lower than critique estimates.
Conclusions:
- Inverse-consistency is crucial for accurate TBM in longitudinal studies.
- The refined TBM method provides reliable metrics for clinical trial design.
- Improved atrophy rate estimation enhances the efficiency of neurodegenerative disease drug development.
Related Concept Videos
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

